Apple started preorders for the Watch Series 12 and Ultra 4 with a new Health Sensing System and the S11 chip. The watches measure heart rate every 5 seconds. This adds higher-frequency heart rate and HRV readings and a real-time heart rate complication to the watch face.
Apple introduced a redesigned Apple Health app alongside Apple Watch Series 12 and Ultra 4, adding an Insights tab plus personalized assessments and guidance using Apple Intelligence. It includes a readiness score and a “Health Age” calculation, and Apple is partnering with Quest for a 50-biomarker panel priced at $119. The app adds a longevity tab and can incorporate lab results, and it will roll out later this year starting in U.S. English.
Apple released the Apple Watch Series 12 and Apple Watch Ultra 4 with upgraded health sensors and new audio transcription and summary features. The Series 12 starts at $399 for the aluminum, non-cellular model, while the Ultra 4 starts at $799. Prices stay the same as prior models and the main differences come from S11-powered features including Apple Intelligence.
Insilico Medicine’s co-CEO Feng Ren said early results from its experimental fibrosis drug trial suggest biology-linked aging could slow. The company reported that patients’ predicted biological age declined by roughly 3 years on average, and up to 6 years on one measure. That supports an AI drug-discovery push toward extending healthspan and potentially making aging-related outcomes easier to target.
Dyson’s CameraJet AI-powered toothbrush is failing for some early buyers because water is getting into the battery compartment. The reported price is $499.99 and one user said their unit broke within 30 seconds. The result is that multiple units show similar wet-battery failures, and customers are reporting faulty batches.
MSK Innovation Accelerator opened applications for its fourth six-month programme dedicated to musculoskeletal innovation in the UK. Each fully funded venture receives more than £80,000 of specialist support, and applications close on 4 October 2026. The accelerator adds a focus area that welcomes AI-related work and offers pitching for investment, with continued support to move technologies from research toward commercialisation.
Anemo Labs raised £700,000 in pre-seed funding to develop an electronic nose that detects disease-related volatile organic compounds from body emissions. In early tests, its machine-learning models classified scent categories 84.15% across 12 categories using the Sniffin' Sticks protocol. The company will use the funding to expand its smell data collection and sensor development and to continue clinical validation for urine-based, non-invasive screening.
Every AI story that matters,
in your inbox by 8am.
TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the
day in two minutes. Follow companies and topics for alerts, or get the
briefing in Slack. Free, no spam, unsubscribe anytime.
Reading TLDRocket needs no cookies, and the readership counts we rely on come from
our own cookieless analytics. Google Analytics is the exception: it sets cookies and
reports to Google, so it stays switched off until you allow it. You can change your
mind any time from “Cookie settings” in the footer.
Strictly necessary
Session security and form protection (tldrocket-session,
XSRF-TOKEN, 2 hours). The site cannot work without them,
so they need no consent.
Always on
Google Analytics 4 (_ga,
_ga_<id>, up to 2 years). Measures which
stories and sections readers use. Google acts as a third-party processor and may
store the data outside the EU. No advertising, no profiling, no data sold.